Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The doses used in animal studies, when adjusted for body weight, may not correspond to the human dose in the supplement
Eligibility & Dose Requirements Proof of your current prescription and dosage is required during your consultation. Your provider will verify your eligibility and determine the appropriate dose based on your treatment history. To qualify for 4.4mg/week, you must have been prescribed at least 2.2mg/week within the past 45 days. To qualify for 7mg/week, you must have been prescribed at least 4.4mg/week within the past 45 days. To qualify for 10mg/week, you must have been prescribed at least 7mg/week within the past 45 days. Patients requesting 13mg/week must have documentation of prior treatment at an appropriate dose, as determined by the prescribing provider
GIP/GLP-1 coagonists: tirzepatideStructure and mechanism of action Tirzepatide (TZP) is the only marketed drug of its kind
Skeletal muscle Nucleo-Mitochondrial crosstalk in obesity and type 2 diabetes
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary gland to increase HGH production, while Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates growth hormone release without significantly impacting cortisol or prolactin levels
(Discard if cloudy.) If you dont know how to calculate the correct dosage a good resource is our peptide calculator here
